Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
- Published In:
- Clinical toxicology (Philadelphia, Pa.), 50(10), 1169-73 (2012)
- Authors:
- Nelson, Michael E, Bryant, Sean M, Aks, Steven E
- Database ID:
- RPEP-02022
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02022APA
Nelson, Michael E; Bryant, Sean M; Aks, Steven E. (2012). Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.. Clinical toxicology (Philadelphia, Pa.), 50(10), 1169-73. https://doi.org/10.3109/15563650.2012.740637
MLA
Nelson, Michael E, et al. "Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.." Clinical toxicology (Philadelphia, 2012. https://doi.org/10.3109/15563650.2012.740637
RethinkPeptides
RethinkPeptides Research Database. "Melanotan II injection resulting in systemic toxicity and rh..." RPEP-02022. Retrieved from https://rethinkpeptides.com/research/nelson-2012-melanotan-ii-injection-resulting
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.